Skip to main content
Grant Details

Grant Number: 5R01CA161608-06 Interpret this number
Primary Investigator: Motsinger-Reif, Alison
Organization: North Carolina State University Raleigh
Project Title: Genetic Etiology of Cancer Drug Response
Fiscal Year: 2018
Back to top


Abstract: Important progress continues to be made in the treatment of most common cancers, but therapeutic benefit remains difficult to predict and severe or fatal adverse events occur frequently. The Human Genome Project has fueled the notion that genetic information can produce effective and cost-efficient selection of therapies for individual patients, but validated genetic signatures that predict response to most chemotherapy regimens remain to be identified. Numerous genes potentially influence drug response, but current candidate-gene approaches are limited by the requirement of a priori knowledge about the genes involved and the moderate size of most clinical trials often limits the power of in vitro genome wide association studies (GWAS) for cancer pharmacogenomics discovery. In response to these limitations, we have undertaken a thorough, pharmacogenomic assessment of cytotoxic effect of the majority of FDA approved anti-cancer compounds using an ex vivo model system to determine the heritability of drug-induced cell killing to prioritize drugs for pharmacogenomic mapping. These results are an important first step, and while high heritability of a trait does not guarantee successful association mapping results, it represents an important first step and the results will be used to prioritize drugs with high heritabilities for genome-wide association mapping. In the current proposal, GWAS mapping of cytotoxic agents will be performed in a European American population, and then replication GWAS mapping will be performed in an East Asian population. In addition to discovering and validating genetic variants that predict drug response, the wealth of data collected will be used to dissect the underlying etiology of drug response traits, including assessing the relative contribution of genetic, environmental, and interaction components of variation. These results will provide crucial insight to prioritize genetic variants for follow-up in precious clinical population resources, and potentially reveal new insight into the overall etiology of drug responses.

Back to top


Gene set analysis methods: a systematic comparison.
Authors: Mathur R. , Rotroff D. , Ma J. , Shojaie A. , Motsinger-Reif A. .
Source: Biodata Mining, 2018; 11, p. 8.
EPub date: 2018-05-31 00:00:00.0.
PMID: 29881462
Related Citations

An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines.
Authors: Roell K.R. , Reif D.M. , Motsinger-Reif A.A. .
Source: Frontiers In Pharmacology, 2017; 8, p. 158.
EPub date: 2017-04-20 00:00:00.0.
PMID: 28473769
Related Citations

Discordance Of Somatic Mutations Between Asian And Caucasian Patient Populations With Gastric Cancer
Authors: Jia F. , Teer J.K. , Knepper T.C. , Lee J.K. , Zhou H.H. , He Y.J. , McLeod H.L. .
Source: Molecular Diagnosis & Therapy, 2016-12-30 00:00:00.0; , .
PMID: 28039579
Related Citations

The Pharmacogenomics Of Drug Resistance To Protein Kinase Inhibitors
Authors: Gillis N.K. , McLeod H.L. .
Source: Drug Resistance Updates : Reviews And Commentaries In Antimicrobial And Anticancer Chemotherapy, 2016 Sep; 28, p. 28-42.
PMID: 27620953
Related Citations

Pharmgkb Summary: Succinylcholine Pathway, Pharmacokinetics/pharmacodynamics
Authors: Alvarellos M.L. , McDonagh E.M. , Patel S. , McLeod H.L. , Altman R.B. , Klein T.E. .
Source: Pharmacogenetics And Genomics, 2015 Dec; 25(12), p. 622-30.
PMID: 26398623
Related Citations

Budget Impact Analysis Of Cyp2c19-guided Voriconazole Prophylaxis In Aml
Authors: Mason N.T. , Bell G.C. , Quilitz R.E. , Greene J.N. , McLeod H.L. .
Source: The Journal Of Antimicrobial Chemotherapy, 2015 Nov; 70(11), p. 3124-6.
PMID: 26233624
Related Citations

Prediction Of Human Population Responses To Toxic Compounds By A Collaborative Competition
Authors: Eduati F. , Mangravite L.M. , Wang T. , Tang H. , Bare J.C. , Huang R. , Norman T. , Kellen M. , Menden M.P. , Yang J. , et al. .
Source: Nature Biotechnology, 2015 Sep; 33(9), p. 933-40.
PMID: 26258538
Related Citations

Population-based In Vitro Hazard And Concentration-response Assessment Of Chemicals: The 1000 Genomes High-throughput Screening Study
Authors: Abdo N. , Xia M. , Brown C.C. , Kosyk O. , Huang R. , Sakamuru S. , Zhou Y.H. , Jack J.R. , Gallins P. , Xia K. , et al. .
Source: Environmental Health Perspectives, 2015 May; 123(5), p. 458-66.
PMID: 25622337
Related Citations

Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).
Authors: Patel J.N. , Jiang C. , Hertz D.L. , Mulkey F.A. , Owzar K. , Halabi S. , Ratain M.J. , Friedman P.N. , Small E.J. , Carducci M.A. , et al. .
Source: Cancer, 2015-04-01 00:00:00.0; 121(7), p. 1025-31.
EPub date: 2015-04-01 00:00:00.0.
PMID: 25417775
Related Citations

An Investigation Of Gene-gene Interactions In Dose-response Studies With Bayesian Nonparametrics
Authors: Beam A.L. , Motsinger-Reif A.A. , Doyle J. .
Source: Biodata Mining, 2015; 8, p. 6.
PMID: 25691918
Related Citations

Pharmacogenomic Assessment Of Mexican And Peruvian Populations
Authors: Marsh S. , King C.R. , Van Booven D.J. , Revollo J.Y. , Gilman R.H. , McLeod H.L. .
Source: Pharmacogenomics, 2015; 16(5), p. 441-8.
PMID: 25916516
Related Citations

Evaluating The Role Of Admixture In Cancer Therapy Via In Vitro Drug Response And Multivariate Genome-wide Associations
Authors: Jack J. , Havener T.M. , McLeod H.L. , Motsinger-Reif A.A. , Foster M. .
Source: Pharmacogenomics, 2015; 16(13), p. 1451-63.
PMID: 26314407
Related Citations

Beyond Ic50 S: Towards Robust Statistical Methods For In Vitro Association Studies
Authors: Beam A. , Motsinger-Reif A. .
Source: Journal Of Pharmacogenomics & Pharmacoproteomics, 2014-03-01 00:00:00.0; 5(1), p. 1000121.
PMID: 25110614
Related Citations

Genome-wide Association And Pharmacological Profiling Of 29 Anticancer Agents Using Lymphoblastoid Cell Lines
Authors: Brown C.C. , Havener T.M. , Medina M.W. , Jack J.R. , Krauss R.M. , McLeod H.L. , Motsinger-Reif A.A. .
Source: Pharmacogenomics, 2014 Feb; 15(2), p. 137-46.
PMID: 24444404
Related Citations

Application Of Next Generation Sequencing To Ceph Cell Lines To Discover Variants Associated With Fda Approved Chemotherapeutics
Authors: Hariani G.D. , Lam E.T. , Lam E.J. , Havener T. , Kwok P.Y. , McLeod H.L. , Wagner M.J. , Motsinger-Reif A.A. .
Source: Bmc Research Notes, 2014; 7, p. 360.
PMID: 24924344
Related Citations

An Adaptive Permutation Approach For Genome-wide Association Study: Evaluation And Recommendations For Use
Authors: Che R. , Jack J.R. , Motsinger-Reif A.A. , Brown C.C. .
Source: Biodata Mining, 2014; 7, p. 9.
PMID: 24976866
Related Citations

Lymphoblastoid Cell Lines Models Of Drug Response: Successes And Lessons From This Pharmacogenomic Model
Authors: Jack J. , Rotroff D. , Motsinger-Reif A. .
Source: Current Molecular Medicine, 2014; 14(7), p. 833-40.
PMID: 25109794
Related Citations

Bayesian Neural Networks For Detecting Epistasis In Genetic Association Studies
Authors: Beam A.L. , Motsinger-Reif A. , Doyle J. .
Source: Bmc Bioinformatics, 2014; 15, p. 368.
PMID: 25413600
Related Citations

Genome-wide association studies in pharmacogenomics: successes and lessons.
Authors: Motsinger-Reif A.A. , Jorgenson E. , Relling M.V. , Kroetz D.L. , Weinshilboum R. , Cox N.J. , Roden D.M. .
Source: Pharmacogenetics And Genomics, 2013 Aug; 23(8), p. 383-94.
PMID: 20639796
Related Citations

Cancer Pharmacogenomics: Early Promise, But Concerted Effort Needed
Authors: McLeod H.L. .
Source: Science (new York, N.y.), 2013-03-29 00:00:00.0; 339(6127), p. 1563-6.
PMID: 23539596
Related Citations

Risk score modeling of multiple gene to gene interactions using aggregated-multifactor dimensionality reduction.
Authors: Dai H. , Charnigo R.J. , Becker M.L. , Leeder J.S. , Motsinger-Reif A.A. .
Source: Biodata Mining, 2013-01-08 00:00:00.0; 6(1), p. 1.
EPub date: 2013-01-08 00:00:00.0.
PMID: 23294634
Related Citations

Loss Of Power In Two-stage Residual-outcome Regression Analysis In Genetic Association Studies
Authors: Che R. , Motsinger-Reif A.A. , Brown C.C. .
Source: Genetic Epidemiology, 2012 Dec; 36(8), p. 890-4.
PMID: 22941732
Related Citations

A Genome-wide Association Analysis Of Temozolomide Response Using Lymphoblastoid Cell Lines Shows A Clinically Relevant Association With Mgmt
Authors: Brown C.C. , Havener T.M. , Medina M.W. , Auman J.T. , Mangravite L.M. , Krauss R.M. , McLeod H.L. , Motsinger-Reif A.A. .
Source: Pharmacogenetics And Genomics, 2012 Nov; 22(11), p. 796-802.
PMID: 23047291
Related Citations

Multivariate Methods And Software For Association Mapping In Dose-response Genome-wide Association Studies
Authors: Brown C.C. , Havener T.M. , Medina M.W. , Krauss R.M. , McLeod H.L. , Motsinger-Reif A.A. .
Source: Biodata Mining, 2012; 5(1), p. 21.
PMID: 23234571
Related Citations

Genomic Profiling In Ceph Cell Lines Distinguishes Between The Camptothecins And Indenoisoquinolines
Authors: Watson,V.G. , Hardison,N.E. , Harris,T. , Motsinger-Reif,A. , McLeod,H.L. .
Source: Molecular Cancer Therapeutics, 2011 Oct; 10(10), p. 1839-45.
PMID: 21750217
Related Citations

Pharmacogenomic Characterization Of Us Fda-approved Cytotoxic Drugs
Authors: Peters,E.J. , Motsinger-Reif,A. , Havener,T.M. , Everitt,L. , Hardison,N.E. , Watson,V.G. , Wagner,M. , Richards,K.L. , Province,M.A. , McLeod,H.L. .
Source: Pharmacogenomics, 2011 Oct; 12(10), p. 1407-15.
PMID: 22008047
Related Citations

Identification And Replication Of Loci Involved In Camptothecin-induced Cytotoxicity Using Ceph Pedigrees
Authors: Watson,V.G. , Motsinger-Reif,A. , Hardison,N.E. , Peters,E.J. , Havener,T.M. , Everitt,L. , Auman,J.T. , Comins,D.L. , McLeod,H.L. .
Source: Plos One, 2011; 6(5), p. e17561.
PMID: 21573211
Related Citations

Optimization Of Nonlinear Dose- And Concentration-response Models Utilizing Evolutionary Computation
Authors: Beam,A.L. , Motsinger-Reif,A.A. .
Source: Dose-response : A Publication Of International Hormesis Society, 2011; 9(3), p. 387-409.
PMID: 22013401
Related Citations

A Comparison Of Association Methods For Cytotoxicity Mapping In Pharmacogenomics
Authors: Brown C. , Havener T.M. , Everitt L. , McLeod H. , Motsinger-Reif A.A. .
Source: Frontiers In Genetics, 2011; 2, p. 86.
PMID: 22303380
Related Citations

Back to Top